Search Results 311-320 of 12455 for alp

1. OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer - Mayo Clinic

   ... alkaline phosphatase (ALP), or total bilirubin. Known Stage IV ovarian cancer with brain metastases. Received an investigational agent in another clinical ...

2. Allogeneic, Culture-Expanded Bone Marrow-Derived Mesenchymal Stem Cells to Treat Painful Lumbar Facet Joint Arthropathies - Mayo Clinic

   ... alkaline phosphatase (ALP), bilirubin, creatinine, CRP, and ESR. Clinical significance is to be determined upon investigator's discretion. * Ongoing ...

3. Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study - Mayo Clinic

   Bilirubin >2x upper limit of normal, in association with AST/ALT/ALP >3x upper limit normal; Allergy to apixaban and warfarin; Subjects requiring taking ...

4. A Study To Evaluate Avacopan In Participants With ANCA-associated Vasculitis - Mayo Clinic

   Aspartate aminotransferase (AST), alanine aminotransferase (ALT), or alkaline phosphatase (ALP) >2.0 times the upper limit of normal (ULN). Total bilirubin ...

5. OTL38 for Intraoperative Imaging of Folate Receptor Positive Lung Nodules - Mayo Clinic

   ... alkaline phosphatase (ALP), or > 2 x ULN for total bilirubin except in subjects with Gilbert's syndrome. Received an investigational agent in another ...

6. High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma - Mayo Clinic

   AST, LDH, and alkaline phosphatase no greater than 2 times ULN; If lactate dehydrogenase or alkaline phosphatase is above normal, a contrast-enhanced CT scan ...

7. Selinexor in Advanced Liposarcoma - Clinical Trials

   Alkaline phosphatase (ALP), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) <3.0 x ULN (except patients with liver involvement of their ...

8. An Extension Study MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue - Mayo Clinic

   -Patients with acute or chronic hepatic dysfunction as evidenced by clinically important (> grade 1) changes in AST, ALT, bilirubin, or albumin, or either ALP ...

9. A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) - Mayo Clinic

   AST, ALT, and ALP ≤ 2.5 x upper limit of normal (ULN); Serum bilirubin ≤ 1.5 x ULN with the following exception: Patients with known Gilbert disease: serum ...

10. Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus - Mayo Clinic

    ALP > 2 × ULN 12. Patient currently receiving any approved treatment for NASH or obesity 13. Current or recent history (< 5 years) of significant alcohol ...